These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 10074199)

  • 21. A single nucleotide substitution in the transcription start signal of the M2 gene of respiratory syncytial virus vaccine candidate cpts248/404 is the major determinant of the temperature-sensitive and attenuation phenotypes.
    Whitehead SS; Firestone CY; Collins PL; Murphy BR
    Virology; 1998 Aug; 247(2):232-9. PubMed ID: 9705916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased genetic and phenotypic stability of a promising live-attenuated respiratory syncytial virus vaccine candidate by reverse genetics.
    Luongo C; Winter CC; Collins PL; Buchholz UJ
    J Virol; 2012 Oct; 86(19):10792-804. PubMed ID: 22837193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of recombinant respiratory syncytial virus gene deletion mutants in African green monkeys for their potential as live attenuated vaccine candidates.
    Jin H; Cheng X; Traina-Dorge VL; Park HJ; Zhou H; Soike K; Kemble G
    Vaccine; 2003 Sep; 21(25-26):3647-52. PubMed ID: 12922094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant human Metapneumovirus lacking the small hydrophobic SH and/or attachment G glycoprotein: deletion of G yields a promising vaccine candidate.
    Biacchesi S; Skiadopoulos MH; Yang L; Lamirande EW; Tran KC; Murphy BR; Collins PL; Buchholz UJ
    J Virol; 2004 Dec; 78(23):12877-87. PubMed ID: 15542640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The live attenuated subgroup B respiratory syncytial virus vaccine candidate RSV 2B33F is attenuated and immunogenic in chimpanzees, but exhibits partial loss of the ts phenotype following replication in vivo.
    Crowe JE; Randolph V; Murphy BR
    Virus Res; 1999 Jan; 59(1):13-22. PubMed ID: 10854162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo.
    Teng MN; Whitehead SS; Collins PL
    Virology; 2001 Oct; 289(2):283-96. PubMed ID: 11689051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attenuated Human Parainfluenza Virus Type 1 Expressing the Respiratory Syncytial Virus (RSV) Fusion (F) Glycoprotein from an Added Gene: Effects of Prefusion Stabilization and Packaging of RSV F.
    Liu X; Liang B; Ngwuta J; Liu X; Surman S; Lingemann M; Kwong PD; Graham BS; Collins PL; Munir S
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28835504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3.
    Schmidt AC; McAuliffe JM; Murphy BR; Collins PL
    J Virol; 2001 May; 75(10):4594-603. PubMed ID: 11312329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of altering the transcription termination signals of respiratory syncytial virus on viral gene expression and growth in vitro and in vivo.
    Tran KC; Collins PL; Teng MN
    J Virol; 2004 Jan; 78(2):692-9. PubMed ID: 14694100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children.
    Karron RA; Wright PF; Crowe JE; Clements-Mann ML; Thompson J; Makhene M; Casey R; Murphy BR
    J Infect Dis; 1997 Dec; 176(6):1428-36. PubMed ID: 9395351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A further attenuated derivative of a cold-passaged temperature-sensitive mutant of human respiratory syncytial virus retains immunogenicity and protective efficacy against wild-type challenge in seronegative chimpanzees.
    Crowe JE; Bui PT; Davis AR; Chanock RM; Murphy BR
    Vaccine; 1994 Jul; 12(9):783-90. PubMed ID: 7975856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant respiratory syncytial virus with the G and F genes shifted to the promoter-proximal positions.
    Krempl C; Murphy BR; Collins PL
    J Virol; 2002 Dec; 76(23):11931-42. PubMed ID: 12414935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rational design of live-attenuated recombinant vaccine virus for human respiratory syncytial virus by reverse genetics.
    Collins PL; Whitehead SS; Bukreyev A; Fearns R; Teng MN; Juhasz K; Chanock RM; Murphy BR
    Adv Virus Res; 1999; 54():423-51. PubMed ID: 10547682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recovery of infectious respiratory syncytial virus expressing an additional, foreign gene.
    Bukreyev A; Camargo E; Collins PL
    J Virol; 1996 Oct; 70(10):6634-41. PubMed ID: 8794298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attenuated Human Parainfluenza Virus Type 1 (HPIV1) Expressing the Fusion Glycoprotein of Human Respiratory Syncytial Virus (RSV) as a Bivalent HPIV1/RSV Vaccine.
    Mackow N; Amaro-Carambot E; Liang B; Surman S; Lingemann M; Yang L; Collins PL; Munir S
    J Virol; 2015 Oct; 89(20):10319-32. PubMed ID: 26223633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered growth characteristics of recombinant respiratory syncytial viruses which do not produce NS2 protein.
    Teng MN; Collins PL
    J Virol; 1999 Jan; 73(1):466-73. PubMed ID: 9847352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate.
    Li X; Sambhara S; Li CX; Ettorre L; Switzer I; Cates G; James O; Parrington M; Oomen R; Du RP; Klein M
    Virology; 2000 Mar; 269(1):54-65. PubMed ID: 10725198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of alpha/beta interferons in the attenuation and immunogenicity of recombinant bovine respiratory syncytial viruses lacking NS proteins.
    Valarcher JF; Furze J; Wyld S; Cook R; Conzelmann KK; Taylor G
    J Virol; 2003 Aug; 77(15):8426-39. PubMed ID: 12857912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation and characterization of a highly attenuated respiratory syncytial virus (RSV) vaccine candidate by mutagenesis of the incompletely attenuated RSV A2 ts-1 NG-1 mutant virus.
    Hsu KH; Crowe JE; Lubeck MD; Davis AR; Hung PP; Chanock RM; Murphy BR
    Vaccine; 1995 Apr; 13(5):509-15. PubMed ID: 7543716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccination with a Single-Cycle Respiratory Syncytial Virus Is Immunogenic and Protective in Mice.
    Schmidt ME; Oomens AGP; Varga SM
    J Immunol; 2019 Jun; 202(11):3234-3245. PubMed ID: 31004010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.